Susquehanna International Group, LLP Enanta Pharmaceuticals Inc Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 73,759 shares of ENTA stock, worth $505,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,759
Previous 36,653
101.24%
Holding current value
$505,986
Previous $202,000
175.74%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ENTA
# of Institutions
106Shares Held
18.7MCall Options Held
50KPut Options Held
0-
Farallon Capital Management LLC San Francisco, CA2.12MShares$14.6 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$14.5 Million8.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$13.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$12.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.46MShares$10 Million0.01% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $142M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...